|
Psychopharmacology
Citations 71-80 of 175 total displayed.
|
Past content
(since Feb 1998):
|
- Letters to the Editor
CUtLASS Confirms CATIE
- Jim Mintz; Alex Kopelowicz
Arch Gen Psychiatry 2007; 64: 978.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
First- vs Second-Generation Antipsychotic Drugs in Schizophrenia—Reply
- Peter B. Jones; Thomas R. E. Barnes; Peter Elton; Linda Davies; Graham Dunn; Helen Lloyd; Karen P. Hayhurst; Robin M. Murray; Alison Marwick; Shôn Lewis
Arch Gen Psychiatry 2007; 64: 979-980.
[Extract]
[Full text]
[PDF]
- Original Articles
Association Between a Functional Serotonin Transporter Promoter Polymorphism and Citalopram Treatment in Adult Outpatients With Major Depression
- Xian-Zhang Hu; A. John Rush; Dennis Charney; Alexander F. Wilson; Alexa J. M. Sorant; George J. Papanicolaou; Maurizio Fava; Madhukar H. Trivedi; Stephen R. Wisniewski; Gonzalo Laje; Silvia Paddock; Francis J. McMahon; Husseini Manji; Robert H. Lipsky
Arch Gen Psychiatry 2007; 64: 783-792.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Lack of Information in Naltrexone Study—Reply
- Sandra D. Comer; Maria A. Sullivan; Elmer Yu; Jami L. Rothenberg; Herbert D. Kleber; Kyle Kampman; Charles Dackis; Charles P. O’Brien
Arch Gen Psychiatry 2007; 64: 865-a.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
Lack of Information in Naltrexone Study
- Darius A. Rastegar
Arch Gen Psychiatry 2007; 64: 865.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
Neonatal Risks of Maternal Treatment With Mood Stabilizers
- Mark Olfson; Steven Marcus
Arch Gen Psychiatry 2007; 64: 866-a-867-a.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
Problems With Maternal Antidepressant Treatment and Neonatal Outcomes Study
- Thomas R. Einarson; Gideon Koren; Adrienne Einarson
Arch Gen Psychiatry 2007; 64: 866.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
Neonatal Risks of Maternal Treatment With Mood Stabilizers—Reply
- Tim F. Oberlander; William Warburton; Shaila Misri; Jaafar Aghajanian; Clyde Hertzman
Arch Gen Psychiatry 2007; 64: 867-868.
[Extract]
[Full text]
[PDF]
- Commentaries
Cognitive Improvement in Response to Antipsychotic Drugs: Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
- R. Walter Heinrichs
Arch Gen Psychiatry 2007; 64: 631-632.
[Extract]
[Full text]
[PDF]
- Original Articles
Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
- Richard S. E. Keefe; Robert M. Bilder; Sonia M. Davis; Philip D. Harvey; Barton W. Palmer; James M. Gold; Herbert Y. Meltzer; Michael F. Green; George Capuano; T. Scott Stroup; Joseph P. McEvoy; Marvin S. Swartz; Robert A. Rosenheck; Diana O. Perkins; Clarence E. Davis; John K. Hsiao; Jeffrey A. Lieberman; for the CATIE Investigators and the Neurocognitive Working Group
Arch Gen Psychiatry 2007; 64: 633-647.
[Abstract]
[Full text]
[PDF]
|
|
